Pall Biotech

Join us for the next webinar series

VIRUS FILTRATION
Get the Job Done!

Webinar On Demand! Register to watch now!

Duration:
2 hours.

Summary

Many biopharmaceutical therapies, such as mAbs and blood plasma factors, are produced using biological materials. This carries the risk that microorganisms such as viral contaminants may be unintentionally introduced into the manufacturing process and contaminate the product. Thus of paramount importance is the removal of such adventitious agents using effective viral filtration methods.

In this webinar, the fundamental principles of virus filtration as well as its practical execution will be discussed. In addition, participants will gain an in-depth understanding of filterability, validation and the local regulatory framework surrounding virus filtration processes. By the conclusion of the session, all attendees should be able to conduct a virus filterability trial and will be well equipped to have appropriate discussions with validation labs.

Speakers

  • Speaker:

    Morven McAlister

    Pall Biotech
    Global Sr. Director, Regulatory and Validation Consultancy

  • Speaker:

    Aernout Martens

    Pall Biotech
    Global Product Manager Virus Filtration

  • Speaker:

    Nigel B. Jackson

    Pall Biotech
    Principal Engineer R&D

  • Speaker:

    Sudhakar Nagaraj

    Pall Biotech
    Principal Scientist, SLS – Global Regulatory and Validation Consulting Group

Register Now!

All fields required